IRIS
DAMIANI, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.423
EU - Europa 4.091
AS - Asia 1.254
SA - Sud America 20
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 2
Totale 18.820
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.321
UA - Ucraina 1.529
DE - Germania 654
CN - Cina 601
FI - Finlandia 502
IT - Italia 425
SG - Singapore 413
SE - Svezia 301
IE - Irlanda 241
RU - Federazione Russa 169
TR - Turchia 111
FR - Francia 102
CA - Canada 97
GB - Regno Unito 75
IN - India 44
IR - Iran 28
VN - Vietnam 28
CZ - Repubblica Ceca 18
BE - Belgio 17
BR - Brasile 17
EU - Europa 13
NL - Olanda 11
TG - Togo 11
PL - Polonia 8
KR - Corea 7
BG - Bulgaria 6
EG - Egitto 6
RO - Romania 6
RS - Serbia 6
HK - Hong Kong 5
CH - Svizzera 4
JP - Giappone 4
AT - Austria 3
HU - Ungheria 3
AR - Argentina 2
AU - Australia 2
DK - Danimarca 2
ES - Italia 2
GL - Groenlandia 2
GR - Grecia 2
ID - Indonesia 2
IL - Israele 2
MX - Messico 2
NO - Norvegia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
EC - Ecuador 1
GE - Georgia 1
KH - Cambogia 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LT - Lituania 1
LU - Lussemburgo 1
Totale 18.820
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.113
Ann Arbor 1.688
Fairfield 1.222
Houston 1.176
Jacksonville 1.104
Chandler 762
Dearborn 590
Ashburn 558
Wilmington 505
Seattle 442
Cambridge 374
Singapore 331
Beijing 310
Boardman 301
Princeton 252
Dublin 240
Izmir 110
Udine 110
San Diego 102
Ottawa 77
Ogden 62
Norwalk 56
Dallas 44
Hefei 41
Trieste 40
Des Moines 38
Nanjing 35
Regensburg 29
Kunming 28
New York 28
Helsinki 26
Dong Ket 25
Los Angeles 22
Munich 22
Guangzhou 21
Santa Clara 20
Simi Valley 19
Augusta 18
Brussels 17
Toronto 17
Jinan 16
Andover 15
Washington 15
Leawood 14
Nanchang 14
Rome 13
Milan 12
San Mateo 12
Fuzhou 11
Lomé 11
Monmouth Junction 11
Brno 10
Grafing 9
Phoenix 9
Zanjan 9
Duino-Aurisina 8
Hebei 8
Mumbai 8
Warsaw 8
Wuhan 8
Ardabil 7
Venice 7
Belgrade 6
Horia 6
Redwood City 6
Saint Petersburg 6
Shenyang 6
Cairo 5
Hangzhou 5
Hong Kong 5
Hyderabad 5
Ningbo 5
Redmond 5
Shanghai 5
Sofia 5
Caserta 4
Edinburgh 4
Frankfurt am Main 4
Napoli 4
Olomouc 4
Parma 4
Zhengzhou 4
Altopascio 3
Amsterdam 3
Arba 3
Bangalore 3
Baotou 3
Changsha 3
Chengdu 3
Florence 3
Lanzhou 3
Lappeenranta 3
London 3
New Delhi 3
Prague 3
Sacramento 3
Secaucus 3
Shaoxing 3
São Paulo 3
Tokyo 3
Totale 13.362
Salva come PNG Salva come JPEG
Nome #
Prognostic significance of the detection of tumour cells in peripheral blood stem cell collections in stage II and III breast cancer patients treated with high-dose therapy 236
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients 181
“Fibre nervose peptidergiche intraepidermiche: uno studio immunoistochimico”. 154
A comparative analysis of the sensitivity of multidrug resistant (MDR) and non MDR cells to different anthracycline derivatives 145
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology 145
Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors 137
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years 132
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients. 129
Histone post-translational modifications associated to BAALC expression in leukemic cells. 129
P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells 128
Clinical feature and outcome in seven patients wuth hyaline or mixed variant of Castleman’s disease. A single centre experience 126
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. 123
B-cell immune reconstitution after allogenic stem cell transplantation and its role in the development of chronic graft-versus-host disease 121
“Overexpression of multidrug resistance-associated P-170 glycoprotein in acute non lymphocytic leukemia”. 120
ABCG2, Cytogenetics, and Age Predict Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission 118
Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia. 118
Autologous stem cell transplantation in chronic carriers of hepatitis B virus and hepatitis C virus affected by onco-hematologic diseases. 118
Efficacy and safety of rituximab in type II mixed cryoglobulinemia 116
Autologus stem cell transplantation as postremission therapy for acute myeloid leukemia. Risk factors at diagnosis can predict the outcome. 115
Granulocyte-macrophage colony -stimulating factor in acute nonlymphocytic leukemia before and after chemo therapy”. 115
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin. 114
P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia 113
P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia. 111
Longitudinal follow-up of WT1 gene expression as monitoring of minimal residual disease in acute myeloid leukemia following allogeneic bone marrow transplant 111
Imatinib mesylate (Glivec) pre-treatment does not have a negative effect on outcome of allogenic hematopoietic stem cell transplantation in Philadelphia-positive leukemias 111
ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome 109
Visualization of PGP 9.5 immunoreactive nerve terminals in the mouse snout epidermis. 108
ABCG2 overexpression and deoxyadenosine analogue activity in acute myeloid leukemia 108
“Long Term Follow-up of the Italian Trial of Interferon-a Versus Conventional Chemotherapy in Chronic Myeloid Leukemia”. 107
Unexpected phenotype of a typical NPM1 mutant 107
Nocardiosis with favourable clinical outcome in progressive B-chronic lymphocytic leukaemia 107
Long-term efficacy and safety of nilotinib therapy after imatinib failure in eosinophilic myeloproliferative neoplasm and ETV6-ABL rearrangement 107
Liposome-encapsulated daunorubicin for PGP-related multidrug resistance 107
“D-Verapamil downmodulates P-170 associated resistance to doxorubicin, daunorubicin and idarubicin”. 106
Impact of fludarabine-based induction therapy on outcome of FLT3-/NPM1+ cytogenetically normal acute myeloid leukemia. 106
“Case report: mdr-1 gene amplification in acute lymphoblastic leukemia prior to antileukemic treatment”. 106
Multipotent Mesenchymal Stem Cells Can Be Isolated and Grown from Many Tissues (Bone Marrow, Liver and Heart) 106
Brain natriuretic peptide level as marker of cardiac function in imatinib--treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy. 105
High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients 105
Clinical factors predictive of myelofibrotic evolution in patients with polycythemia vera. 104
CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis”. 103
“Espressione dell’antigene CD34 nei tessuti normali e patologici e possibili applicazioni cliniche delle cellule CD34”. 102
Erratum: Functional regulation of the Apurinic/apyrimidinic endonuclease APE1 by Nucleophosmin (NPM1): Impact on tumor biology 102
Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia 102
ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML 102
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype 102
“CD34+ selected versus un-manipulated autologous stem cell transplantation in multiple myeoloma: impact on dendritic and immune recovery and on complications due to infections”. 101
BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine 101
Flow cytometry evaluation of plasma cells contaminating leukapheresis pre- and post- CD34-positive selection- 100
Multipotent cells can be generated in vitro from several adult human organs (heart, liver and bone marrow) 100
Antibody binding capacity for evaluation of MDR-related proteins in acute promyelocytic leukemia: Onset versus relapse expression 100
FEASIBILITY OF ALLOGENEIC STEM CELL TRANSPLANTATION WITH CD34 SELECTED STEM CELLS: OUTCOME AND IMMUNOLOGICAL COMPLICATIONS 99
Suggestive evidence for a Microanatomical Relationship betweeb Mast Cells and Nerve Fibres Containing Substance P, Calcitonin Gene Related Peptide, Vasoactive Intestinal Polypeptide, and Somatostatin in the rat Mesentery. 98
Intensified full-dose induction therapy (HD-MACHOP+radiotherapy) follwed dy consolidation with BAVC regimen and autologous stem cell transplantation as fron-line therapeutic approach for high risk aggressive non Hodgkin lymphoma 97
Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy. 97
“Expression of Multidrug resistance gene (MDR 1) in normal hematopoietic cells”. 96
Multidrug resistance modulation in vivo. The effect of cyclosporin alone or with dextro-verapamil on idarubicin pharmacokinetics in acute leukemia 96
Screening for multidrug resistance in leukemia: cell reactivity to MRK-16 correlates with anthracycline retention and sensitivity of leukemic cells. 95
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia 95
Acute promyelocytic leucemia: low expression of multidrug resistance phenotype at onset suggest a favourable effect of gentuzumab ozogamicyn (CMA-676 94
Cytokines dysregulation and chronic graft versus host disease after allogeneic haematopoieitc stem cell transplantation with reduced intensity conditioning 94
Peripheral blood stem cell mobilization in multiple myeloma: advantage of 7 vs. 4 g/m2 cyclophosfamide on stem cell quality and plasma cell mobilization. 93
Dendritic cell recovery after autologous stem cell transplantation 93
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure 93
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients. 93
CONCOMITANT BCRP OVER-EXPRESSION AND FLT3-ITD MUTATION IDENTIFY A SUBSET OF ACUTE MYELOID LEUKEMIA PATIENTS AT HIGH RISK OF RELAPSE 91
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 years treated with induction regimens including fludarabine: retrospective analysis of 224 cases 90
5-AZACITIDINE FIVE DAYS/MONTHLY SCHEDULE IN SYMPTOMATIC LOW-RISK (IPSS: 0-1) MYELODISPLASTIC (MDS) PATIENTS. CLINICAL AND BIOLOGICAL EFFECTS Authors 90
Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy. 89
KIR POLYMORPHISM IN REDUCED INTENSITY HLA-ID SIBLING STEM CELL TRANSPLANTATION: IMPACT ON CLINICAL OUTCOME 89
Comparison between the L-DOPA histofluorescence procedure and the indirect immunofluorescence with anti-T6 and -HLA-DR monoclonal antibodies in visualizing Langerhans cells of human epidermis 89
Proliferation and maturation effects of in vivo granulo-monocyte colony stimulating factor in acute non-lymphocytic leucemia”. 88
DENDRITIC CELL RECOVERY AFTER AUTOLOGOUS AND ALLOGENEIC TRANSPLANTATION 88
“Treatment of Ph+ chronic myeloid leukemia by gamma interferon”. 88
“Immunohistochemical detection of the multidrug transport protein P170 in human normal tissues and malignant lymphomas”. 88
Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation 87
The expression of the multidrug resistance related glycoprotein in adult acute lymphoblastic leukemia. 87
Serotoninergic fibres form dense synaptic contacts with Purkinje cells in the mouse cerebellar cortex--an immunohistochemical study 87
The expression of the multidrug resistance-associated glycoprotein in B-cell chronic lymphocytic leucemia 87
Effect of fludarabine and arabinosylcytosine on multidrug resistant cells. 86
FEASIBILITY AND OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS OLDER THAN 60 YEARS WITH POOR RISK ACUTE MYELOID LEUKEMIA 86
Isolation, characterization and in vitro growth of human multipotent adult cardiac progenitor cells 86
A study of the material in the ATLAS inner detector using secondary hadronic interactions 86
Acute promyelocyttic leucemia: low expression of multidrug resistance phenotype at onset suggests a favorable effect of Gemtuzumab Ozogamycin (CMA 676) 85
Overexpression of MDR-related p170 glycoprotein in chronic myeloid leukemia. 85
Improvement of amyloid-related symptoms after autologous stem cell transplantation in a patient with hepatomegaly, macroglossia and purpura 85
Fludarabine, Arabynosil cytosine and Idarubicin (FLAI), a combination of non MDR related drugs for tratment of patients with newly diagnosed acute myeloi leukemia. 84
A mutational status of IGVH genes consisten with antigen-driven selection has prognostic impact istead of percento f mutations in B-cell chronic lymphocytic leukemia 84
Sequential study of cytokine and lymphocyte patterns in patients with chronic agraft versus host disease after reduced intensity conditioning allogenic stem cell transplantation 84
Clinical characteristics, prognostic factors and multidrug-resistance related protein expression in 36 adult patients with acute promyelocytic leukemia 83
P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) in de novo adult acute lymphoblastica leukemia 83
Treatment intensification of malignant lymphomas with autologous bone marrow transplantation and granulocyte colony stimulating factor. 82
KERATOCONJUNCTIVITIS TREATMENT WITH AUTOLOGOUS SERUM EYE IN PATIENTS WITH SEVERE CHRONIC GVHD 82
P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias 81
Efficacy of tuemor necrosis factor alfa blockade with infliximab for the treatment of svere steroid-refractory acute graft versus host disease. 81
Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies. 81
“Multidrug resistance (MDR1) in acute myelogenous leukemia: is it time to test?” 80
“The use of G-CSF during first line chemotherapy adversely affects the yield of PBSC mobilization in non-Hodgkins’ Lymphoma patients” 80
Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults. 80
Invasive fungal infections in allogneic haematopoietic stem cell transplantation: 12 years experience on 246 patients at a single institution 80
Totale 10.294
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.084
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.084
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.971 0 0 0 0 0 791 460 529 264 443 116 368
2020/20212.774 44 309 21 364 71 404 154 343 493 68 414 89
2021/20221.898 53 276 69 167 64 47 78 103 19 311 396 315
2022/20231.861 273 97 16 226 188 519 6 149 254 31 57 45
2023/2024600 98 58 35 27 71 84 10 33 86 44 13 41
2024/20251.080 87 346 209 117 140 181 0 0 0 0 0 0
Totale 19.156